发明授权
- 专利标题： Compositions and methods for inhibition of the JAK pathway
- 专利标题（中）： 用于抑制JAK途径的组合物和方法
-
申请号： US12645349申请日： 2009-12-22
-
公开(公告)号： US08268851B2公开(公告)日： 2012-09-18
- 发明人: Somasekhar Bhamidipati , Hui Li , Rajinder Singh , Vanessa Taylor , Jeffrey Clough , Darren McMurtrie
- 申请人： Somasekhar Bhamidipati , Hui Li , Rajinder Singh , Vanessa Taylor , Jeffrey Clough , Darren McMurtrie
- 申请人地址： US CA South San Francisco
- 专利权人： Rigel Pharmaceuticals, Inc.
- 当前专利权人： Rigel Pharmaceuticals, Inc.
- 当前专利权人地址： US CA South San Francisco
- 代理机构： Klarquist Sparkman, LLP
- 主分类号： A01N43/54
- IPC分类号： A01N43/54 ; A61K31/505
摘要：
The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.
公开/授权文献
信息查询
IPC分类:
